title: Osteoporosis therapies in 2014.
abstract: Osteoporosis is a systemic disorder characterized by low bone mass and microarchitectural deterioration of bone tissue with a consequent increase in bone fragility and susceptibility to fracture. It has a significant impact on public health through the increased morbidity, mortality, and economic costs associated with fractures. Despite the severe medical and socioeconomic consequences of fragility fractures, relatively few adults with fractures are evaluated and/or treated for osteoporosis. In this review, we summarize the existing treatment options and promising new therapies for the prevention and treatment of osteoporosis.
authors.affiliation: MRC Lifecourse Epidemiology Unit University of Southampton Southampton General Hospital, Southampton, UK - emd@mrc.soton.ac.uk.
authors.forename: A
authors.initials: A
authors.lastname: Litwic
authors.forename: C
authors.initials: C
authors.lastname: Cooper
authors.forename: E
authors.initials: E
authors.lastname: Dennison
mesh_terms: D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*
chemical_list: D050071:Bone Density Conservation Agents